EBT was founded on the discovery of the Saphenous nerve’s role in modulating pelvic health function, enabling entirely new approaches to treating a wide variety of indications, beginning with overactive bladder.

Spun out of the University of Toronto, EBT Medical is a venture-backed, clinical-stage company developing paradigm-shifting neuromodulation technologies focused on treating pelvic health disorders via the Saphenous nerve.

EBT’s vision is to completely reimagine how pelvic health disorders are treated– elevating neuromodulation from a last-line alternative to the forefront of every patient’s journey.

EBT Medical is backed by world-class investors including SV Health Investors and Genesys Capital. Our Medical Advisory Board includes leading experts in the pelvic health space, and our impressive, diverse management team has decades of experience in Class II & III medical devices, with proven track records in neuromodulation and pelvic health.